A. G6 PD
B. 6 phosphogluconate dehydrogenase
C. Transketolase
D. Transaldolase
Related Mcqs:
- Which of the following is not a product of HMP shunt_____________?
A. NADPH
B. D fructose 6 phosphate
C. D sedoheptulose 5 phosphate
D. D glyceraldehyde 3 phosphate - Sites where HMP shunts can occur include_______________?
A. Liver
B. WBC
C. Lactating mammary gland
D. Testes
E. All of the above - HMP shunt is of great importance in cellular metabolism because its produces_____________?
A. ATP
B. ADP
C. Acetyl CoA
D. NADPH - The citric acid cycle is the final pathway for oxidation of______________?
A. Enzymes
B. Vitamins
C. Minerals
D. None of the above - The main pathway for De – Novo synthesis of fatty acids occurs in_______________?
A. Mitochondria
B. Nucleus
C. Cytosol
D. None of the above - Which is not seen in HMG CoA pathway ?
A. Pyruvate
B. Cholesterol
C. Mevalonate
D. Acetyl CoA - The main site of fluoride inhibition in the Embden Meyerhof pathway of acid____________?
A. ATPase
B. Enolase
C. Pyruvate Kinase
D. Fructose 6 phosphatase - Drug not requiring dose adjustment in renal disease is___________?
A. Aminoglycoside
B. Vancomycin
C. Calcium channel blocker
D. Metronidazole - Cardiac condition requiring Antibiotic prophylaxis for infective Endocarditis ?
A. Coronary Heart Disease
B. Rheumatic Heart Disease
C. Cardiac Pacemakers
D. Hypertensive Heart Disease - Clotting factor common to extrinsic and intrinsic pathway is_____________?
A. Factor II
B. Factor III
C. Factor V
D. Factor VII